Diamyd Medical (Sweden) Buy Hold or Sell Recommendation
DMYD-B Stock | SEK 11.18 1.58 16.46% |
Assuming the 90 days trading horizon and your conservative attitude towards risk, our recommendation regarding Diamyd Medical AB is 'Strong Sell'. Macroaxis provides Diamyd Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DMYD-B positions. The advice algorithm takes into account all of Diamyd Medical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Diamyd Medical's buy or sell advice are summarized below:
Real Value 9.22 | Hype Value 9.6 | Market Value 11.18 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Diamyd Medical AB given historical horizon and risk tolerance towards Diamyd Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Diamyd Medical AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Diamyd |
Execute Diamyd Medical Buy or Sell Advice
The Diamyd recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Diamyd Medical AB. Macroaxis does not own or have any residual interests in Diamyd Medical AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Diamyd Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Modest | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Diamyd Medical Trading Alerts and Improvement Suggestions
Diamyd Medical AB is way too risky over 90 days horizon | |
Diamyd Medical AB appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 454 K. Net Loss for the year was (118.18 M) with loss before overhead, payroll, taxes, and interest of (3.95 M). | |
Diamyd Medical AB has accumulated about 119.76 M in cash with (93.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02. | |
Roughly 35.0% of the company shares are held by company insiders |
Diamyd Medical Returns Distribution Density
The distribution of Diamyd Medical's historical returns is an attempt to chart the uncertainty of Diamyd Medical's future price movements. The chart of the probability distribution of Diamyd Medical daily returns describes the distribution of returns around its average expected value. We use Diamyd Medical AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Diamyd Medical returns is essential to provide solid investment advice for Diamyd Medical.
Mean Return | 0.47 | Value At Risk | -5.85 | Potential Upside | 11.04 | Standard Deviation | 6.53 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Diamyd Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Diamyd Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Diamyd Medical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Diamyd Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Diamyd stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.42 | |
β | Beta against NYSE Composite | 0.44 | |
σ | Overall volatility | 6.96 | |
Ir | Information ratio | 0.06 |
Diamyd Medical Volatility Alert
Diamyd Medical AB is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Diamyd Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Diamyd Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Diamyd Medical Fundamentals Vs Peers
Comparing Diamyd Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Diamyd Medical's direct or indirect competition across all of the common fundamentals between Diamyd Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Diamyd Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Diamyd Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Diamyd Medical by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Diamyd Medical to competition |
Fundamentals | Diamyd Medical | Peer Average |
Return On Equity | -0.42 | -0.31 |
Return On Asset | -0.25 | -0.14 |
Operating Margin | (170.83) % | (5.51) % |
Current Valuation | 1.06 B | 16.62 B |
Shares Outstanding | 76.93 M | 571.82 M |
Shares Owned By Insiders | 35.22 % | 10.09 % |
Shares Owned By Institutions | 0.26 % | 39.21 % |
Price To Earning | (4.21) X | 28.72 X |
Price To Book | 5.67 X | 9.51 X |
Price To Sales | 2,531 X | 11.42 X |
Revenue | 454 K | 9.43 B |
Gross Profit | (3.95 M) | 27.38 B |
EBITDA | (98.88 M) | 3.9 B |
Net Income | (118.18 M) | 570.98 M |
Cash And Equivalents | 119.76 M | 2.7 B |
Cash Per Share | 1.02 X | 5.01 X |
Current Ratio | 5.83 X | 2.16 X |
Book Value Per Share | 2.36 X | 1.93 K |
Cash Flow From Operations | (93.22 M) | 971.22 M |
Earnings Per Share | (1.45) X | 3.12 X |
Number Of Employees | 20 | 18.84 K |
Beta | 1.91 | -0.15 |
Market Capitalization | 1.21 B | 19.03 B |
Total Asset | 236.52 M | 29.47 B |
Retained Earnings | (31 M) | 9.33 B |
Working Capital | 28 M | 1.48 B |
Current Asset | 33 M | 9.34 B |
Current Liabilities | 5 M | 7.9 B |
Net Asset | 236.52 M |
Diamyd Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Diamyd . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Diamyd Medical Buy or Sell Advice
When is the right time to buy or sell Diamyd Medical AB? Buying financial instruments such as Diamyd Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Diamyd Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
View All Next | Launch |
Check out Diamyd Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |